| Description |
| Product Type |
Product Size |
| Tablet |
20'S |
| Product Company |
| Shaigen Pharmaceuticals |
Meloxicam 7.5mg |
| Product Type |
Product Size |
| Tablet |
100'S |
| Product Company |
| Wilson Pharmaceuticals |
Orphenadrine citrate 35mg, paracetamol 450mg |
| Product Type |
Product Size |
| Tablets |
15'S |
| Product Company |
| Searle Pharma |
Paracetamol and Orphenadrine Citrate |
| Product Type |
Product Size |
Product Company |
| Injection |
1'S |
Sandoz |
|
| Product Type |
Product Size |
| Tablets |
30'S |
| Product Company |
| Sami Pharmaceutical |
Dexibuprofen 400mg |
| Product Type |
Product Size |
| Tablet |
200'S |
| Product Company |
| Pfizer/td> |
Mefenamic Acid 500mg |
| Content | Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve various types of pain, including pain caused by musculoskeletal conditions, osteoarthritis, and rheumatoid arthritis.
| Orphenadrine citrate is a skeletal muscle relaxant. It acts in the central nervous system to produce muscle relaxant effects. Paracetamol is used to treat or prevent pain and reduce fever. | Nuberol Forte® (Paracetamol 650 mg + Orphenadrine 50 mg) for the symptomatic management of the painful musculoskeletal disorders one tablet three times a day or as per physician discretion or as per severity of pain and treatment duration is 7-10 days. | Oxaliplatin is a platinum based chemotherapy agent used to treat carcinoma of the colon or rectum or stage III colon cancer. | Dexibuprofen Tablets are used to relieve: - pain and inflammation caused by osteoarthritis/ arthritis (joint inflammation, joint wear and tear); - period (menstrual) pain; - mild to moderate pain, such as musculoskeletal pain, headache and toothache; painful swelling and inflammation after injury | Mefenamic acid is a member of the anthranilic acid derivatives class of nonsteroidal anti-inflammatory drugs, and is used to treat mild to moderate pain. Its name derives from its systematic name, dimethylphenyl aminobenzoic acid. |
Reviews
There are no reviews yet.